Cite
Hyperparathyroidism in patients over 75: Clinical characteristics and outcome. Is conservative treatment a safe alternative?
MLA
Talia Diker-Cohen, et al. “Hyperparathyroidism in Patients over 75: Clinical Characteristics and Outcome. Is Conservative Treatment a Safe Alternative?” Maturitas, vol. 135, May 2020, pp. 47–52. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c378b3a470b348d859ad065359480754&authtype=sso&custid=ns315887.
APA
Talia Diker-Cohen, Eyal Robenshtok, Hiba Masri-Iraqi, Dania Hirsch, Hadar Duskin-Bitan, Ilan Shimon, Ilana Slutzky-Shraga, Alexander Gorshtein, Joelle Singer, Gloria Tsvetov, & Nina Nemirovsky. (2020). Hyperparathyroidism in patients over 75: Clinical characteristics and outcome. Is conservative treatment a safe alternative? Maturitas, 135, 47–52.
Chicago
Talia Diker-Cohen, Eyal Robenshtok, Hiba Masri-Iraqi, Dania Hirsch, Hadar Duskin-Bitan, Ilan Shimon, Ilana Slutzky-Shraga, et al. 2020. “Hyperparathyroidism in Patients over 75: Clinical Characteristics and Outcome. Is Conservative Treatment a Safe Alternative?” Maturitas 135 (May): 47–52. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c378b3a470b348d859ad065359480754&authtype=sso&custid=ns315887.